Form 4 for TWST Twist Bioscience Corp
Accepted 2022-02-03 00:00:00 ET · period of report 2022-02-01 · accession 0001214659-22-001811 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-03 | 2022-02-01 | TWST | Finn Patrick John | Chief Commercial Off | S - Sale+OE | $60.52 | -659 | 43.5K | -1% | -$39.9K |
| DM | 2022-02-03 | 2022-02-01 | TWST | Finn Patrick John | Chief Commercial Off | M - OptEx | $25.25 | +659 | 43.7K | +2% | +$16.6K |
| DM | 2022-02-03 | 2022-02-01 | TWST | Finn Patrick John | Chief Commercial Off | M - OptEx | $0.00 | -659 | 34.5K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-01 | S | D | 659 | $60.52 | 43,452 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-01 | M | A | 379 | $26.66 | 44,111 | D | — | — | |
| 3 | Common | Common Stock | 2022-02-01 | M | A | 280 | $23.33 | 43,732 | D | — | — | |
| 4 | Derivative | Employee Stock Option (right to buy) | 2022-02-01 | M | D | 280 | $0.00 | 19,705 | D | $23.33 · — to 2029-10-23 | 280 Common Stock | (F3) 25% of the shares subject to the option vested and became exercisable on October 24, 2020, and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. |
| 5 | Derivative | Employee Stock Option (right to buy) | 2022-02-01 | M | D | 379 | $0.00 | 34,512 | D | $26.66 · — to 2028-11-18 | 379 Common Stock | (F2) 20% of the shares subject to the option vested and became exercisable on October 31, 2019, and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. |